An Evaluation of the Cost Effectiveness of Drotrecogin Alfa (Activated) Relative to the Number of Organ System Failures

Author: Betancourt M.  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.21, Iss.18, 2003-01, pp. : 1331-1340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract